{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:51:44Z","timestamp":1781877104016,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Sciences, and Technology of Japan","doi-asserted-by":"crossref","award":["23H00552"],"award-info":[{"award-number":["23H00552"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019670","name":"BIKEN foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019670","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49127-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:24:30Z","timestamp":1777112670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of cellular receptors on the vaccine efficacies of adenovirus vector-based vaccines following intramuscular and intranasal administration"],"prefix":"10.1038","volume":"16","author":[{"given":"Rika","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"49127_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.medj.2020.11.004","volume":"1","author":"F Krammer","year":"2020","unstructured":"Krammer, F. Pandemic vaccines: How are we going to be better prepared next time?. Med 1, 28\u201332 (2020).","journal-title":"Med"},{"key":"49127_CR2","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMp2005630","volume":"382","author":"N Lurie","year":"2020","unstructured":"Lurie, N., Saville, M., Hatchett, R. & Halton, J. Developing Covid-19 vaccines at pandemic speed. N. Engl. J. Med. 382, 1969\u20131973 (2020).","journal-title":"N. Engl. J. Med."},{"key":"49127_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2021.100432","volume":"42","author":"F Sakurai","year":"2022","unstructured":"Sakurai, F., Tachibana, M. & Mizuguchi, H. Adenovirus vector-based vaccine for infectious diseases. Drug Metab. Pharmacokinet. 42, 100432 (2022).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"49127_CR4","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.ymthe.2025.03.062","volume":"33","author":"NR Hackett","year":"2025","unstructured":"Hackett, N. R. & Crystal, R. G. Four decades of adenovirus gene transfer vectors: History and current use. Mol. Ther. 33, 2192\u20132204 (2025).","journal-title":"Mol. Ther."},{"key":"49127_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/vaccines13040406","volume":"13","author":"MST Murala","year":"2025","unstructured":"Murala, M. S. T., Gairola, V., Sayedahmed, E. E. & Mittal, S. K. Next-generation adenoviral vector-based vaccines for severe acute respiratory syndrome Coronavirus-2. Vaccines 13, 406 (2025).","journal-title":"Vaccines"},{"key":"49127_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","volume":"132","author":"ZC Hartman","year":"2008","unstructured":"Hartman, Z. C., Appledorn, D. M. & Amalfitano, A. Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 132, 1\u201314 (2008).","journal-title":"Virus Res."},{"key":"49127_CR7","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/JVI.02192-06","volume":"81","author":"J Zhu","year":"2007","unstructured":"Zhu, J., Huang, X. & Yang, Y. Innate immune response to adenoviral vectors is mediated by both toll-like receptor-dependent and -independent pathways. J. Virol. 81, 3170\u20133180 (2007).","journal-title":"J. Virol."},{"key":"49127_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/hum.2007.016","volume":"18","author":"T Yamaguchi","year":"2007","unstructured":"Yamaguchi, T. et al. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum. Gene Ther. 18, 753\u2013762 (2007).","journal-title":"Hum. Gene Ther."},{"key":"49127_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1128\/JVI.02702-13","volume":"88","author":"E Lam","year":"2014","unstructured":"Lam, E., Stein, S. & Falck-Pedersen, E. Adenovirus detection by the cGAS\/STING\/TBK1 DNA sensing cascade. J. Virol. 88, 974\u2013981 (2014).","journal-title":"J. Virol."},{"key":"49127_CR10","doi-asserted-by":"publisher","first-page":"17286","DOI":"10.1073\/pnas.1009823107","volume":"107","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi, T. et al. Induction of type i interferon by adenovirus-encoded small RNAs. Proc. Natl. Acad. Sci. U. S. A. 107, 17286\u201317291 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"49127_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102282","volume":"80","author":"S Marquez-Martinez","year":"2023","unstructured":"Marquez-Martinez, S., Vijayan, A., Khan, S. & Zahn, R. Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines. Curr. Opin. Immunol. 80, 102282 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"49127_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis, N. & Ertl, H. C. J. Adenoviruses as vaccine vectors. Mol. Ther. 10, 616\u2013629 (2004).","journal-title":"Mol. Ther."},{"key":"49127_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/v16030377","volume":"16","author":"L Scarsella","year":"2024","unstructured":"Scarsella, L. et al. Advances of recombinant adenoviral vectors in preclinical and clinical applications. Viruses 16, 377 (2024).","journal-title":"Viruses"},{"key":"49127_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson, J. M. et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320\u20131323 (1997).","journal-title":"Science"},{"key":"49127_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","volume":"73","author":"TJ Wickham","year":"1993","unstructured":"Wickham, T. J., Mathias, P., Cheresh, D. A. & Nemerow, G. R. Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment. Cell 73, 309\u2013319 (1993).","journal-title":"Cell"},{"key":"49127_CR16","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","volume":"79","author":"DM Shayakhmetov","year":"2005","unstructured":"Shayakhmetov, D. M., Gaggar, A., Ni, S., Li, Z.-Y. & Lieber, A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79, 7478\u20137491 (2005).","journal-title":"J. Virol."},{"key":"49127_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.3107","volume":"19","author":"Z Xu","year":"2013","unstructured":"Xu, Z. et al. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat. Med. 19, 452\u2013457 (2013).","journal-title":"Nat. Med."},{"key":"49127_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1517\/17425247.2014.938637","volume":"11","author":"E Lopez-Gordo","year":"2014","unstructured":"Lopez-Gordo, E., Denby, L., Nicklin, S. A. & Baker, A. H. The importance of coagulation factors binding to adenovirus: Historical perspectives and implications for gene delivery. Expert Opin. Drug Deliv. 11, 1795\u20131813 (2014).","journal-title":"Expert Opin. Drug Deliv."},{"key":"49127_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","volume":"132","author":"SN Waddington","year":"2008","unstructured":"Waddington, S. N. et al. Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer. Cell 132, 397\u2013409 (2008).","journal-title":"Cell"},{"key":"49127_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/JVI.79.2.1053-1061.2005","volume":"79","author":"DM Shayakhmetov","year":"2005","unstructured":"Shayakhmetov, D. M., Eberly, A. M., Li, Z.-Y. & Lieber, A. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 79, 1053\u20131061 (2005).","journal-title":"J. Virol."},{"key":"49127_CR21","doi-asserted-by":"publisher","first-page":"16756","DOI":"10.1038\/srep16756","volume":"5","author":"MDJ Dicks","year":"2015","unstructured":"Dicks, M. D. J. et al. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice. Sci. Rep. 5, 16756 (2015).","journal-title":"Sci. Rep."},{"key":"49127_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ymthe.2003.10.010","volume":"9","author":"M Akiyama","year":"2004","unstructured":"Akiyama, M. et al. Ablating CAR and integrin binding in adenovirus vectors reduces nontarget organ transduction and permits sustained bloodstream persistence following intraperitoneal administration. Mol. Ther. 9, 218\u2013230 (2004).","journal-title":"Mol. Ther."},{"key":"49127_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2012.05.025","volume":"164","author":"AC Bradshaw","year":"2012","unstructured":"Bradshaw, A. C. et al. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses. J. Control. Release 164, 394\u2013402 (2012).","journal-title":"J. Control. Release"},{"key":"49127_CR24","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","volume":"116","author":"R Alba","year":"2010","unstructured":"Alba, R. et al. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood 116, 2656\u20132664 (2010).","journal-title":"Blood"},{"key":"49127_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.gt.3301701","volume":"9","author":"H Mizuguchi","year":"2002","unstructured":"Mizuguchi, H. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther. 9, 769\u2013776 (2002).","journal-title":"Gene Ther."},{"key":"49127_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","volume":"114","author":"R Alba","year":"2009","unstructured":"Alba, R. et al. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: Effect of mutagenesis on FX interactions and gene transfer. Blood 114, 965\u2013971 (2009).","journal-title":"Blood"},{"key":"49127_CR27","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/mtm.2016.1","volume":"3","author":"F Sakurai","year":"2016","unstructured":"Sakurai, F. et al. Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus. Mol. Ther. Methods Clin. Dev. 3, 16001 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"49127_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1476-4598-9-130","volume":"9","author":"M Irigoyen","year":"2010","unstructured":"Irigoyen, M. et al. Tgfbi expression is associated with a better response to chemotherapy in NSCLC. Mol. Cancer 9, 130 (2010).","journal-title":"Mol. Cancer"},{"key":"49127_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102430","volume":"14","author":"MA Juratli","year":"2022","unstructured":"Juratli, M. A. et al. Integrin \u03b12 and \u03b21 cross-communication with mTOR\/AKT and the CDK-cyclin axis in hepatocellular carcinoma cells. Cancers 14, 2430 (2022).","journal-title":"Cancers"},{"key":"49127_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3171\/jns.2000.92.6.1002","volume":"92","author":"K Asaoka","year":"2000","unstructured":"Asaoka, K., Tada, M., Sawamura, Y., Ikeda, J. & Abe, H. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J. Neurosurg. 92, 1002\u20131008 (2000).","journal-title":"J. Neurosurg."},{"key":"49127_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-4165(01)00194-5","volume":"1568","author":"N Koizumi","year":"2001","unstructured":"Koizumi, N. et al. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim. Biophys. Acta 1568, 13\u201320 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"49127_CR32","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1073\/pnas.0711757105","volume":"105","author":"O Kalyuzhniy","year":"2008","unstructured":"Kalyuzhniy, O. et al. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 105, 5483\u20135488 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"49127_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169-184.e13 (2020).","journal-title":"Cell"},{"key":"49127_CR34","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.celrep.2021.109452","volume":"36","author":"AO Hassan","year":"2021","unstructured":"Hassan, A. O. et al. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 36, 109452 (2021).","journal-title":"Cell Rep."},{"key":"49127_CR35","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1016\/j.vaccine.2017.04.062","volume":"35","author":"JA Fonseca","year":"2017","unstructured":"Fonseca, J. A. et al. A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice. Vaccine 35, 3239\u20133248 (2017).","journal-title":"Vaccine"},{"key":"49127_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","volume":"12","author":"B Pulendran","year":"2011","unstructured":"Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 12, 509\u2013517 (2011).","journal-title":"Nat. Immunol."},{"key":"49127_CR37","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1016\/j.celrep.2020.02.111","volume":"30","author":"S Ols","year":"2020","unstructured":"Ols, S. et al. Route of vaccine administration alters antigen trafficking but not innate or adaptive immunity. Cell Rep. 30, 3964-3971.e7 (2020).","journal-title":"Cell Rep."},{"key":"49127_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2020.09.040","volume":"183","author":"A Iwasaki","year":"2020","unstructured":"Iwasaki, A. & Omer, S. B. Why and how vaccines work. Cell 183, 290\u2013295 (2020).","journal-title":"Cell"},{"key":"49127_CR39","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1242\/jcs.111.16.2397","volume":"111","author":"E Hirsch","year":"1998","unstructured":"Hirsch, E., Lohikangas, L., Gullberg, D., Johansson, S. & F\u00e4ssler, R. Mouse myoblasts can fuse and form a normal sarcomere in the absence of beta1 integrin expression. J. Cell Sci. 111, 2397\u20132409 (1998).","journal-title":"J. Cell Sci."},{"key":"49127_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/aja.1002010203","volume":"201","author":"E Hirsch","year":"1994","unstructured":"Hirsch, E. et al. Alpha v integrin subunit is predominantly located in nervous tissue and skeletal muscle during mouse development. Dev. Dyn. 201, 108\u2013120 (1994).","journal-title":"Dev. Dyn."},{"key":"49127_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/10430349950018409","volume":"10","author":"J Nalbantoglu","year":"1999","unstructured":"Nalbantoglu, J., Pari, G., Karpati, G. & Holland, P. C. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum. Gene Ther. 10, 1009\u20131019 (1999).","journal-title":"Hum. Gene Ther."},{"key":"49127_CR42","doi-asserted-by":"publisher","first-page":"124480","DOI":"10.1016\/j.ijpharm.2024.124480","volume":"662","author":"R Onishi","year":"2024","unstructured":"Onishi, R. et al. Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6\/7 regions of adenovirus serotype 5. Int. J. Pharm. 662, 124480 (2024).","journal-title":"Int. J. Pharm."},{"key":"49127_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.hlife.2025.05.001","volume":"3","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings. hLife 3, 433\u2013447 (2025).","journal-title":"hLife"},{"key":"49127_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","volume":"9","author":"M Xing","year":"2024","unstructured":"Xing, M. et al. An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza. NPJ Vaccines 9, 64 (2024).","journal-title":"NPJ Vaccines"},{"key":"49127_CR45","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 4081 (2020).","journal-title":"Nat. Commun."},{"key":"49127_CR46","doi-asserted-by":"publisher","first-page":"112721","DOI":"10.1016\/j.isci.2025.112721","volume":"28","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Mucosal boosting increases protective efficacy of an influenza vaccine in mice. iScience 28, 112721 (2025).","journal-title":"iScience"},{"key":"49127_CR47","doi-asserted-by":"publisher","first-page":"eadu7646","DOI":"10.1126\/scitranslmed.adu7646","volume":"17","author":"C Jacob-Dolan","year":"2025","unstructured":"Jacob-Dolan, C. et al. Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques. Sci. Transl. Med. 17, eadu7646 (2025).","journal-title":"Sci. Transl. Med."},{"key":"49127_CR48","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","volume":"25","author":"M Gagne","year":"2024","unstructured":"Gagne, M. et al. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates. Nat. Immunol. 25, 1913\u20131927 (2024).","journal-title":"Nat. Immunol."},{"key":"49127_CR49","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/mt.2009.130","volume":"17","author":"MO Lasaro","year":"2009","unstructured":"Lasaro, M. O. & Ertl, H. C. J. New insights on adenovirus as vaccine vectors. Mol. Ther. 17, 1333\u20131339 (2009).","journal-title":"Mol. Ther."},{"key":"49127_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/87720","volume":"2","author":"SM Kaech","year":"2001","unstructured":"Kaech, S. M. & Ahmed, R. Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in na\u00efve cells. Nat. Immunol. 2, 415\u2013422 (2001).","journal-title":"Nat. Immunol."},{"key":"49127_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451142","volume":"55","author":"L Yong","year":"2025","unstructured":"Yong, L., Hutchings, C., Barnes, E., Klenerman, P. & Provine, N. M. Distinct requirements for CD4+ T cell help for immune responses induced by mRNA and adenovirus-vector SARS-CoV-2 vaccines. Eur. J. Immunol. 55, e202451142 (2025).","journal-title":"Eur. J. Immunol."},{"key":"49127_CR52","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1126\/sciimmunol.abb6808","volume":"6","author":"N Swarnalekha","year":"2021","unstructured":"Swarnalekha, N. et al. T resident helper cells promote humoral responses in the lung. Sci. Immunol. 6, 6808 (2021).","journal-title":"Sci. Immunol."},{"key":"49127_CR53","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.4049\/jimmunol.1302806","volume":"192","author":"NM Provine","year":"2014","unstructured":"Provine, N. M. et al. Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses. J. Immunol. 192, 5214\u20135225 (2014).","journal-title":"J. Immunol."},{"key":"49127_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","volume":"10","author":"JX Li","year":"2022","unstructured":"Li, J. X. et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: A randomised, open-label, single-centre trial. Lancet Respir. Med. 10, 739\u2013748 (2022).","journal-title":"Lancet Respir. Med."},{"key":"49127_CR55","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1080\/22221751.2022.2119169","volume":"11","author":"AI Tukhvatulin","year":"2022","unstructured":"Tukhvatulin, A. I. et al. Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates. Emerg. Microbes Infect. 11, 2229\u20132247 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"49127_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1063679","volume":"13","author":"R Sunagar","year":"2022","unstructured":"Sunagar, R., Prasad, S. D., Ella, R. & Vadrevu, K. M. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152). Front. Immunol. 13, 1063679 (2022).","journal-title":"Front. Immunol."},{"key":"49127_CR57","doi-asserted-by":"publisher","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","volume":"7","author":"MDJ Dicks","year":"2012","unstructured":"Dicks, M. D. J. et al. A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity. PLoS One 7, e40385 (2012).","journal-title":"PLoS One"},{"key":"49127_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl8213","volume":"7","author":"AT Baker","year":"2021","unstructured":"Baker, A. T. et al. ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Sci. Adv. 7, eabl8213 (2021).","journal-title":"Sci. Adv."},{"key":"49127_CR59","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher, A. et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N. Engl. J. Med. 384, 2092\u20132101 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49127_CR60","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz, N. H. et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 384, 2124\u20132130 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49127_CR61","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMc2105869","volume":"384","author":"K-L Muir","year":"2021","unstructured":"Muir, K.-L., Kallam, A., Koepsell, S. A. & Gundabolu, K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N. Engl. J. Med. 384, 1964\u20131965 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49127_CR62","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1182\/blood.2024027675","volume":"146","author":"YC Chen","year":"2025","unstructured":"Chen, Y. C. et al. Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: A novel biophysical mechanism for arterial thrombosis. Blood 146, 496\u2013503 (2025).","journal-title":"Blood"},{"key":"49127_CR63","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/sj.gt.3303019","volume":"14","author":"S Murakami","year":"2007","unstructured":"Murakami, S. et al. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther. 14, 1525\u20131533 (2007).","journal-title":"Gene Ther."},{"key":"49127_CR64","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","volume":"304","author":"NJ Pillon","year":"2013","unstructured":"Pillon, N. J., Bilan, P. J., Fink, L. N. & Klip, A. Cross-talk between skeletal muscle and immune cells\u202f: Muscle-derived mediators and metabolic implications. Am. J. Physiol. Endocrinol. Metab. 304, E453\u2013E465 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"49127_CR65","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/10430349950017374","volume":"10","author":"H Mizuguchi","year":"1999","unstructured":"Mizuguchi, H. & Kay, M. A. A simple method for constructing E1- and E1\/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10, 2013\u20132017 (1999).","journal-title":"Hum. Gene Ther."},{"key":"49127_CR66","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.gt.3301453","volume":"8","author":"H Mizuguchi","year":"2001","unstructured":"Mizuguchi, H. et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8, 730\u2013735 (2001).","journal-title":"Gene Ther."},{"key":"49127_CR67","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1089\/hum.1998.9.17-2577","volume":"9","author":"H Mizuguchi","year":"1998","unstructured":"Mizuguchi, H. & Kay, M. A. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9, 2577\u20132583 (1998).","journal-title":"Hum. Gene Ther."},{"key":"49127_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","volume":"36","author":"JV Maizel","year":"1968","unstructured":"Maizel, J. V., White, D. O. & Scharff, M. D. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36, 115\u2013125 (1968).","journal-title":"Virology"},{"key":"49127_CR69","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/mp200121z","volume":"8","author":"K Shimizu","year":"2011","unstructured":"Shimizu, K., Sakurai, F., MacHitani, M., Katayama, K. & Mizuguchi, H. Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector. Mol. Pharm. 8, 1430\u20131435 (2011).","journal-title":"Mol. Pharm."},{"key":"49127_CR70","doi-asserted-by":"publisher","first-page":"e006558","DOI":"10.1136\/jitc-2022-006558","volume":"13","author":"R Ono","year":"2025","unstructured":"Ono, R. et al. Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity. J. Immunother. Cancer. 13, e006558 (2025).","journal-title":"J. Immunother. Cancer."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49127-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49127-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49127-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:03:20Z","timestamp":1781874200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49127-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49127"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49127-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All of the animal experiments performed in this study were approved by the Animal Experiment Committee of The University of Osaka (approval no. 28\u20133-3).\u00a0All procedures were performed in accordance with the ethical standards of the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health, and ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19154"}}